![Highlights! Brian Ortega badly rolls ankle during intros, pulls off gutsy submission over Yair Rodriguez | UFC Mexico City - MMAmania.com Highlights! Brian Ortega badly rolls ankle during intros, pulls off gutsy submission over Yair Rodriguez | UFC Mexico City - MMAmania.com](https://cdn.vox-cdn.com/thumbor/rvs2YT-w1fGsX0_0a77SHNIQTCs=/0x0:7918x5279/1200x800/filters:focal(2453x638:3719x1904)/cdn.vox-cdn.com/uploads/chorus_image/image/73162831/2036911067.0.jpg)
Highlights! Brian Ortega badly rolls ankle during intros, pulls off gutsy submission over Yair Rodriguez | UFC Mexico City - MMAmania.com
![Santhera and ReveraGen Complete NDA Submission to FDA for Vamorolone in Duchenne Muscular Dystrophy - CureDuchenne Santhera and ReveraGen Complete NDA Submission to FDA for Vamorolone in Duchenne Muscular Dystrophy - CureDuchenne](https://cureduchenne.org/wp-content/uploads/2022/10/SYNTHERA-2WEB-POST-HEADER.png)
Santhera and ReveraGen Complete NDA Submission to FDA for Vamorolone in Duchenne Muscular Dystrophy - CureDuchenne
![Legend Biotech, J&J finish off rolling submission for CAR-T hopeful, approach finish line | Fierce Biotech Legend Biotech, J&J finish off rolling submission for CAR-T hopeful, approach finish line | Fierce Biotech](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1617619190/Genscript%20Legend%20Biotech.png/Genscript%20Legend%20Biotech.png?VersionId=pIdRexRCwiJRh5G7QiMCLwqnyRuSj8Cm)
Legend Biotech, J&J finish off rolling submission for CAR-T hopeful, approach finish line | Fierce Biotech
![SpringWorks on X: "We are happy to have initiated the rolling submission of our New Drug Application with the FDA for our investigational MEK inhibitor in pediatric and adult patients with neurofibromatosis SpringWorks on X: "We are happy to have initiated the rolling submission of our New Drug Application with the FDA for our investigational MEK inhibitor in pediatric and adult patients with neurofibromatosis](https://pbs.twimg.com/media/GH0wd0IWYAAxrvW.jpg:large)
SpringWorks on X: "We are happy to have initiated the rolling submission of our New Drug Application with the FDA for our investigational MEK inhibitor in pediatric and adult patients with neurofibromatosis
FALA- Friedreich Ataxia Lebanese Association - ---- REPOST ---- FARA تقدم رائع! لكل المهتمين ببعض التوضيحات حول الأومافيلوكسولون: - أعلنت شركة الأدوية REATA أنه تم تقديم جزءًا من طلب الدواء الجديد (NDA)
![Shorter timelines, evolving strategies: Four key trends in regulatory approvals of new medicines - Clarivate Shorter timelines, evolving strategies: Four key trends in regulatory approvals of new medicines - Clarivate](https://clarivate.com/wp-content/uploads/2022/07/Median-submission-lag-and-approval-times-for-NASs-approved-by-Access-Consortium-members-between-2018-2021-1024x501.jpg)